InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,318.22
(
-0.02%
)
US TECH 100
17,955.80
(
0.18%
)
Dow Jones
39,404.41
(
-0.11%
)
Brent Oil
79.22
(
0.60%
)
Bitcoin
59,910.55
(
-2.96%
)
Post# of 252816
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 45
Posts 4633
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 226892

Thursday, 11/14/2019 8:33:39 AM

Thursday, November 14, 2019 8:33:39 AM

Post# of 252816

According to the AASLD webcast, ASMB thinks HBsAg has little if any consequence as a predictor of a complete response (i.e. cure) to chronic HBV



Roche and JNJ probably don't agree with this assertion as the rich deals they struck to get RNAi drugs for hep b is probably because of the ability of the drugs to lower HBsAg
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up